<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04616144</url>
  </required_header>
  <id_info>
    <org_study_id>EHospitalP</org_study_id>
    <nct_id>NCT04616144</nct_id>
  </id_info>
  <brief_title>Fresh Corneal Lenticule Implantation in Hyperopic Patients With High Astigmatism</brief_title>
  <official_title>Fresh Corneal Lenticule Implantation in Hyperopic Patients With High Astigmatism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eye Hospital Pristina Kosovo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eye Hospital Pristina Kosovo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The refractive combination of high hyperopia with high astigmatism is difficult to treat&#xD;
      surgically. In addition, there are not many suitable options to offer such patients&#xD;
      presenting with this condition. The method used at the EYE Hospital Pristina using fresh&#xD;
      lenticule implantation by ReLex-SMILE is safe and effective method. Fresh Corneal&#xD;
      Implantation is a safe treatment for hyperopia with high astigmatism comparing with&#xD;
      refractive IOL implantation (loss of accommodation, endophthalmitis). Its primary objective&#xD;
      is to increase visual acuity, accommodation process, patient satisfaction which makes patient&#xD;
      to enjoy a happier life. We believe this study will be the future of refractive surgery for&#xD;
      treating high hyperopia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is to investigate the effect of fresh corneal lenticule implantation as allogenic&#xD;
      implant that will be taken from myopic patients to implant in hyperopic patients with high&#xD;
      astigmatism using VisuMax Femtosecond laser - Smile module surgery with primary objective to&#xD;
      assess (increase) visual acuity (far, intermediate, near vision) and secondary objective to&#xD;
      stabilize (decrease) high astigmatism by reducing K-values.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 1, 2019</start_date>
  <completion_date type="Anticipated">May 1, 2024</completion_date>
  <primary_completion_date type="Actual">May 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Miopic Group Hyperopic Group</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Miopic Group Hyperopic Group</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Increase of visual acuity, accommodation process</measure>
    <time_frame>12 months</time_frame>
    <description>Using fresh myopic corneal lenticule resulted in the increase of the visual acuity (far, intermediate and near vision)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Decrease of high hyperopic astigmatism</measure>
    <time_frame>12 months</time_frame>
    <description>In order to stabilize high hyperopic astigmatism and reduce K-values, the myopic fresh corneal lenticule was implanted.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">55</enrollment>
  <condition>Hyperopia</condition>
  <condition>High Astigmatism</condition>
  <arm_group>
    <arm_group_label>FRESH CORNEAL LENTICULE IMPLANTATION</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The aim of this study is to investigate the effect of fresh corneal lenticule implantation as allogenic implant that will be taken from myopic patients to implant in hyperopic patients with high astigmatism using VisuMax Femtosecond Laser-Smile module surgery with primary objective to assess(increase) visual acuity (far, intermediate, near vision) and secondary objective to stabilize(decrease) high astigmatism by reducing K values. Fresh corneal lenticule implantation as allogenic implant that we took from myopic patients (-5.0D) to implant in hyperopic patients (+4.0 D +3.0cyl) according to high K2 values. The stromal pocket diameter was 8 mm, 4mm super incision and 130-µm cap thickness.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fresh Corneal Lenticule Implantation using Relex-Smile VisuMax Femtosecond Laser</intervention_name>
    <description>Fresh Corneal Lenticule Implantation using ReLex-Smile</description>
    <arm_group_label>FRESH CORNEAL LENTICULE IMPLANTATION</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients with high spherical hyperopia over + 4.5 D&#xD;
&#xD;
          -  astigmatism over + 3 cyl.&#xD;
&#xD;
          -  corneal thickness minimum 450 µm and maximum 550 µm.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  corneal thickness over 550 µm&#xD;
&#xD;
          -  history of glaucoma&#xD;
&#xD;
          -  retinal detachment&#xD;
&#xD;
          -  cataract&#xD;
&#xD;
          -  history of ocular inflammation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Eye Hospital Pristina</name>
      <address>
        <city>Pristina</city>
        <zip>10000</zip>
        <country>Kosovo</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Kosovo</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>October 26, 2020</study_first_submitted>
  <study_first_submitted_qc>October 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 4, 2020</study_first_posted>
  <last_update_submitted>June 6, 2021</last_update_submitted>
  <last_update_submitted_qc>June 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Eye Hospital Pristina Kosovo</investigator_affiliation>
    <investigator_full_name>Dr. Faruk Semiz</investigator_full_name>
    <investigator_title>Head of Ophthalmology Department</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Astigmatism</mesh_term>
    <mesh_term>Hyperopia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

